A comparison of two techniques for induction of anaesthesia with target‐controlled infusion of propofol

Summary Induction of anaesthesia with target‐controlled infusion of propofol may be achieved by stepwise increases in effect‐site concentration until the patient loses consciousness (titration method), or by setting a high effect‐site concentration target and observing the calculated effect‐site con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anaesthesia 2018-12, Vol.73 (12), p.1507-1514
Hauptverfasser: Mu, J. J., Jiang, T., Deng, L. P., Choi, S. W., Irwin, M. G., Yuen, V. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Induction of anaesthesia with target‐controlled infusion of propofol may be achieved by stepwise increases in effect‐site concentration until the patient loses consciousness (titration method), or by setting a high effect‐site concentration target and observing the calculated effect‐site concentration at loss of consciousness (standard method). When the estimated effect‐site concentration at loss of consciousness is accurate, the difference between effect‐site concentration at loss of consciousness and at recovery of consciousness should be small. This prospective, randomised, controlled trial was designed to compare this difference (effect‐site concentration at loss of consciousness – effect‐site concentration at recovery of consciousness) associated with the two techniques. Sixty‐seven healthy patients undergoing elective hemithyroidectomy were recruited. Induction of anaesthesia was achieved using effect‐site target‐controlled infusion with the modified Marsh model and ke0 of 1.2 min−1. The median (IQR [range]) difference between effect‐site concentration at loss of consciousness and recovery of consciousness was significantly lower in patients in the titration group at 1.2 (0.8–1.5 [0.1–2.9]) μg.ml−1 compared with the standard group 2.1 (1.9–2.6 [0.2–3.6] μg.ml−1; p 
ISSN:0003-2409
1365-2044
DOI:10.1111/anae.14355